Microbiology Department 2021 New Grant Awards
Explore all of the new grants awarded to Microbiology team members for 2021.
Saswati Biswas, CBID COBRE Pilot Project, Improve production and bioactivity of lantibiotic MU1140 for inhibition of gram-positive pathogens, 10/27/2021 – 5/31/2022
Severin Gudima, FY21 Winter Enhancement Award, Influence of integrant-derived HBV RNAs encoding the envelope proteins on HBV life cycle, 2/1/2021 – 1/31/2022
Maria Kalamvoki, FY21 Winter Enhancement Award, Exosomal STING during HSV-1 infection: properties and function, 2/1/2021 – 1/31/2022
Jianming Qiu, FY21 Winter Enhancement Award, Modulation of SARS-CoV-2 infection in polarized human airway epithelial cultures, 2/1/2021 – 1/31/2022
Jianming Qiu (Co-I), Peachtree, Effects and mechanisms of pharmacologic ascorbate in inhibiting SARS-CoV-2 in pre-clinical models, 01/12/2021 – 07/11/2021
Indranil Biswas, KINBRE Bridge, Arginine phosphorylation and its role in physiology of streptococci, 5/1/2021 – 4/30/2022
Maria Kalamvoki, KINBRE Bridge, Intercellular communication through the stimulator of interferon genes STING during herpes simplex virus 1 infection, 5/1/2021 – 4/30/2022
Jianming Qiu and Ziying Yan (University of Iowa), NIH R21 AI156448, Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways, 06/15/2021 – 05/31/2023
Severin Gudima, NIH R21 AI155819, Regulation of HDV life cycle by the immune response to HBV infection, 06/16/2021 – 05/31/2023
Maria Kalamvoki, NIH R01 AI162784, Cargo, biogenesis and functions of extracellular vesicles released during HSV-1 infection, 07/01/2021 – 06/30/2026
Severin Gudima, NIH R21 AI163722, Regulation of the life cycle of HDV by the drug resistance mutations of HBV, 07/23/2021 – 06/30/2023
Jianming Qiu, NIH R21 R21 AI166293, Identification of the AAVR-independent AAV entry pathway, 09/24/2021 – 08/31/2023
Michele Pritchard (Pharmacology), Jeffrey Bose (Co-I) and Mary Markiewicz (Co-I), Mathers Foundation, Modulation of Staphylococcus aureus skin infection and repair by the hyaluronan network, 10/15/2021 – 10/14/2024